Combined therapy with ceftriaxone and doxycycline does not improve the outcome of meningococcal meningitis in mice compared to ceftriaxone monotherapy

BACKGROUND: Meningococcal meningitis (MM) is a life-threatening disease associated with approximately 10% case fatality rates and neurological sequelae in 10–20% of the cases. Recently, we have shown that the matrix metalloproteinase (MMP) inhibitor BB-94 reduced brain injury in a mouse model of MM....

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :BMC Infect Dis
Главные авторы: Ricci, Susanna, Grandgirard, Denis, Masouris, Ilias, Braccini, Tiziana, Pozzi, Gianni, Oggioni, Marco R., Koedel, Uwe, Leib, Stephen L.
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2020
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7359289/
https://ncbi.nlm.nih.gov/pubmed/32660552
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12879-020-05226-w
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы